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Recent work has achieved the feat of activating the DNA damage checkpoint in the absence of
DNA damage, revealing the importance of protein-chromatin associations for the activation,
amplification and maintenance of the DNA damage response.
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Detecting and repairing DNA damage is critical for the
faithful transmission of genetic information. In response to
DNA lesions, cells activate a complex cellular response,
which at its core consists of a signal transduction cascade
controlled by members of the PI(3) kinase-like kinase
(PIKK) family [1,2]. This signaling cascade, often referred to
as the DNA damage checkpoint, primarily aims to co-
ordinate DNA repair with the arrest or slowing down of the
cell cycle (the checkpoint). Failure to detect and repair DNA
damage can lead to cell death or to genome aberrations that
can promote the development of cancer.
Like other signaling systems, such as those that operate at
the cell surface, DNA damage signaling is under tight spatial
and temporal control. The spatial component of this
pathway is particularly evident during the response to DNA
double-strand breaks (DSBs), the most harmful type of DNA
lesion. DSBs elicit the rapid accumulation of DNA damage
signaling and repair proteins on the chromatin that
surrounds lesions, forming distinctive subnuclear foci [1,2]
that are easily detectable by fluorescence microscopy. What
is extraordinary about this response is not that there is
protein recruitment per se; rather, it is the scale of the
phenomenon that is impressive. Indeed, protein recruitment
after the induction of DSBs can extend for tens of kilobases
on either side of the lesion [3,4]. By inference, DSBs
promote the recruitment of dozens, if not hundreds, of
molecules to the surrounding chromatin. As described
below, protein recruitment at DNA lesions often occurs in a
hierarchical manner and involves multiple post-translational
modifications. Why is DNA damage signaling organized this
way? Recent work published by Evi Soutoglou and Tom
Misteli in Science [5] and by David Toczyski and colleagues
in  Molecular Cell (Bonilla  et al. [6]) address this critical
question by reverse-engineering the DNA damage response,
to spectacular effect.
R Re ec cr ru ui it tm me en nt t   o of f   c ch he ec ck kp po oi in nt t   p pr ro ot te ei in ns s   t to o   D DN NA A   l le es si io on ns s
Soutoglou and Misteli [5] and Bonilla et al. [6] investigate
DNA damage signaling in mouse cells and in Saccharomyces
cerevisiae, respectively. It is therefore useful to briefly
compare and contrast the early response to DSBs in these
species. In mammalian cells, DSBs are thought to be sensed
by the MRE11/RAD50/NBS1 (MRN) complex, which
recruits and activates ATM (ataxia telangiectasia mutated), a
PIKK-family kinase that orchestrates the DNA damage
response (for reviews see [1,2]). Activated ATM triggers the
rapid phosphorylation of the histone 2A variant H2AX to
form what is referred to as γ-H2AX. Strikingly, the size of the
γ-H2AX chromatin domain can extend up to a megabase,
which serves to demarcate the area on which DNA damage
signaling and repair proteins accumulate. The phospho-
epitope formed on γ-H2AX is specifically recognized by the
proteins MCPH1 and MDC1. The consequences of MDC1
recruitment by γ-H2AX are the better understood. MDC1
amplifies ATM-dependent signaling by shielding γ-H2AX
from the action of phosphatases and histone-exchange
factors. In addition, it promotes the accumulation of
additional MRN and activated ATM molecules at DNAlesions via specific phosphorylation-dependent interactions
and also promotes the recruitment of other DSB signaling and
repair proteins. This pathway is summarized in Figure 1a.
DNA damage signaling ultimately leads to activation of the
checkpoint protein kinases Chk1 and Chk2, which modify
components of the cell-cycle machinery to cause cell-cycle
arrest.
In S. cerevisiae, the recognition and response to DSBs does
not primarily depend on ATM, but on a signaling pathway
initiated by a complex of the protein kinase Mec1 and its
regulatory protein Ddc2 [2]. Mec1 is the yeast homolog of
the human protein kinase ATR (ataxia telangiectasia
related), which in humans is primarily concerned with the
checkpoint response to replication fork-blocking lesions.
Mec1-Ddc2 defines one of two DNA damage signaling com-
plexes in yeast that localize independently to DSBs, the other
being the Rad17-Mec3-Ddc1 complex (referred to here as
9-1-1). The recruitment of Mec1-Ddc2 requires the 5’-3’
resection of the DSB to produce tracts of single-stranded
DNA (ssDNA), which become coated with the ssDNA-
binding protein replication protein A (RPA). RPA recruits
the Mec1-Ddc2 complex via a direct interaction with Ddc2.
The 9-1-1 complex is loaded onto sites of DNA damage at the
junction between double-stranded DNA (dsDNA) and the
RPA-bound  ssDNA by a complex composed of Rad24 and
the Rfc2-5 proteins. How the co-localization of these two
complexes leads to activation of Mec1 remains unclear,
although it is becoming increasingly evident that the 9-1-1
complex plays an important role [7,8].
The massive accumulation of signaling and repair proteins
to sites of DNA damage prompted Soutoglou and Misteli [5]
and Bonilla et al. [6] and to ask whether protein recruitment
alone was sufficient to activate checkpoint signaling. Both
groups performed the same simple yet elegant experiment:
they integrated an array of Lac operators (LacO) repeats, the
binding site for the Lac repressor (LacR), in the genomes of
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Engineering DNA damage signaling without DNA damage. ( (a a) ) The response to DNA double-strand breaks (DSBs) in human cells. The MRN complex
localizes to the DNA ends and promotes the recruitment of the protein kinase ATM. ATM phosphorylates histone H2AX to γ-H2AX, which promotes the
assembly of MDC1, 53BP1 and RNF8 (not shown) at the site of the DSB. In turn, the recruitment of MDC1 promotes the amplification of the signaling
cascade by recruiting additional ATM molecules over many kilobases. Chk1 and Chk2 are the checkpoint kinases that are activated by the DNA damage
response and interact with cell-cycle components to cause the arrest of the cell cycle. ( (b b) ) Tethering of ATM to an array of Lac operator sites (LacO) via
the Lac repressor (LacR) promotes the formation of γ-H2AX and recruitment of MRN, MDC1 and 53BP1, followed by activation of Chk1 and Chk2.
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LacRmouse or S. cerevisiae cells. Figure 1b shows the experiment
in human cells. The expression of proteins fused to the
repressor then allowed their tethering to the chromatin of
the LacO array. In essence, this strategy mimics the accumu-
lation of repair and signaling proteins triggered by DNA
lesions, with the important exception that there was no prior
DNA damage.
Both groups made the startling observation that this
experimental scheme resulted in a robust DNA damage
response when the appropriate proteins were fused to LacR.
The concordance of these results is particularly striking
because, as outlined above, the DNA damage responses in
yeast and in humans are initiated by different signaling
pathways. Therefore, it seems that a universal feature of the
initiation and amplification of DNA damage signaling sys-
tems in eukaryotes, be they ATM- or ATR/Mec1-based, is the
concentration of key proteins on chromatin. In addition,
beyond this exciting core finding, both studies revealed more
about the inner workings of DNA damage signaling.
P Pl la as st ti ic ci it ty y   o of f   m me et ta az zo oa an n   A AT TM M- -b ba as se ed d   D DN NA A   d da am ma ag ge e
s si ig gn na al li in ng g
Soutoglou and Misteli [5] primarily assessed activation of
DNA damage signaling by the formation of a γ-H2AX focus
at the LacO array. Using this readout, they found that
checkpoint signaling can be achieved by recruitment to the
LacO array of any one of the proteins NBS1, MRE11, MDC1
or a fragment of ATM (ATM1300-3060). Individual tethering of
the effector kinases Chk1 or Chk2, the kinases whose actions
lead to the cell-cycle arrest, does not prompt checkpoint
signaling, however. These observations reveal a surprising
plasticity in the initiation of the DNA damage response.
Indeed, they implicitly suggest that initiation of DNA
damage signaling may not be by a stereotypical cascade of
protein recruitment at sites of DNA damage, but rather that
an initial accumulation of any one of the MRN, ATM or
MDC1 proteins might be sufficient to trigger ATM activation.
The DNA damage response elicited by tethering MRN or
MDC1 to the LacO array was largely ATM-dependent and
led to cell-cycle arrest at the G2 to M transition, thereby
recapitulating many aspects of the cellular response
initiated by DSBs [6]. A few important differences are
apparent, however. One concerns the activation of the
G2/M checkpoint. Recent work has suggested that the
ATM-dependent G2/M checkpoint might not be sensitive
enough to respond to a single DSB and that a threshold of
around 20 DSBs might be necessary [9,10]. Why a
checkpoint is observed when MDC1, MRN or ATM are
tethered to the LacO array is unclear as it should mimic the
response that occurs at a single DSB. It perhaps indicates
that the physical tethering of these proteins overrides some
control mechanism that establishes the threshold number
of DSBs or threshold ATM activity necessary to trigger the
G2/M checkpoint.
A second discrepancy concerns the strange behavior of
53BP1 recruitment following the tethering of MDC1 and
MRN. Indeed, 53BP1 accumulation at sites of DNA damage
is almost entirely dependent on MDC1 [11], yet only the
physical tethering of MRN, but not that of MDC1, leads to
the formation of 53BP1 foci [5]. If the trivial possibility that
the MDC1-LacR fusion is interfering with 53BP1 recruitment
can be experimentally rejected, this would suggest that
MDC1 recruitment to the LacO array might not be sufficient
to trigger the ubiquitination cascade mediated by the E3
ubiquitin ligase RNF8 that is necessary for 53BP1
recruitment [12-14], whereas MRN somehow can. It will
therefore be interesting to study how RNF8-dependent
protein ubiquitination is normally initiated by the MRN
complex at sites of DNA damage.
Y Ye ea as st t   M Me ec c1 1   s si ig gn na al li in ng g: :   9 9- -1 1- -1 1   c ca al ll ls s   i in n
In contrast to the results in mouse cells, in yeast [6] the
tethering of any one protein to the LacO array was unable to
activate checkpoint signaling, as monitored by phosphorylation
of the yeast Chk2 ortholog Rad53. Rather, Bonilla et al. [6]
needed to simultaneously target LacR fusions of Ddc2 and
components of the 9-1-1 complex to the LacO array in order to
achieve Rad53 activation and a G2/M checkpoint. Importantly,
the response required the presence of Rad9, the yeast homolog
of 53BP1, demonstrating that the signaling triggered by the
combined recruitment of Ddc2 and 9-1-1 recapitulated most
aspects of a normal DNA damage response.
The power of S. cerevisiae as a genetic system allowed Bonilla
et al. [6] to dissect the response triggered by the artificial
recruitment of Ddc1 and Ddc2 to chromatin. Firstly, they found
that the Rad24-based complex that loads 9-1-1 at ssDNA-
dsDNA junctions became redundant, in terms of checkpoint
activation, when 9-1-1 was tethered to the LacO array.
Moreover, the integrity of the 9-1-1 complex itself was not
essential to promote the activation of the DNA damage
response. Indeed, when Ddc1 was immobilized to chromatin
next to Mec1 via LacR fusions, checkpoint signaling could still
be initiated in cells that had deletions in the genes coding for
Mec3 and Rad17, the two partners of Ddc1 in 9-1-1. This latter
result is particularly significant because it suggests that Rad24,
Mec3 and Rad17 are primarily required to localize Ddc1, which
is an activator of Mec1. Future work will address whether this
activation is direct or via other proteins. Nevertheless, these
experiments provide an elegant explanation for the previous
observation that the Ddc2-Mec1 and 9-1-1 complexes are
independently recruited to sites of DNA lesions, as they suggest
that co-localization of two or more complexes to chromatin
provides a fail-safe mechanism that prevents spurious
activation of the DNA damage response.
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system to investigate the observation that Mec1 signaling in
response to certain types of DSBs is regulated by a cell’s
position in the cell cycle. Indeed, cell-cycle position greatly
influences the type of repair and signaling pathways
(whether ATM or Mec1/ATR-based) elicited by DSBs [15-17].
This ‘choice’ is regulated by the status of the DNA lesion,
namely whether it is resected to uncover the ssDNA tracts
needed for ATR activation, or whether the DNA end is
‘stable’, which shunts the signaling pathway to ATM [18].
DNA-end resection is cell-cycle regulated, primarily by
cyclin-dependent kinase (CDK) activity [15,16,18]. In G1,
when CDK activity is lowest, resection is less efficient,
translating into a downregulated Mec1 response [16,19].
However, if CDK activity were solely required during Mec1-
dependent signaling to promote DNA resection, one would
predict that the tethering of Ddc1 (9-1-1) and Ddc2 to the
LacO array should produce a cell-cycle-independent activa-
tion of Mec1. Surprisingly, when this experiment was carried
out, Rad53 phosphorylation was not detected [6]. This
result, along with a clever strategy that allowed Bonilla et al.
to experimentally turn off CDK activity, revealed an unsus-
pected role for CDKs in maintaining an active checkpoint
signal. The authors postulate that this occurs via the phos-
phorylation of Rad9, a key activator that promotes Rad53
phosphorylation by Mec1.
Taken together, both reports show that localization and
accumulation of the appropriate proteins to chromatin is
sufficient for the initiation and amplification of the DNA
damage signal, whether DNA damage is present or not.
These important observations not only provide a new experi-
mental system for dissecting the DNA damage response but
also put a new emphasis on the importance of the protein-
chromatin associations. Finally, we note that just as the
assembly of protein-chromatin complexes is essential for the
initiation and amplification of the DNA damage response,
their disassembly will assuredly be critical for termination of
DNA damage signaling following repair.
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